<antigenSupportingData>
<immunity>
</immunity>
<contraindications>
<vaccineGroup>
<contraindication>
<observationCode>080</observationCode>
<observationTitle>Adverse reaction to vaccine component</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had an adverse reaction to a vaccine component.</contraindicationText>
<beginAge/>
<endAge/>
</contraindication>
<contraindication>
<observationCode>082</observationCode>
<observationTitle>Severe allergic reaction after previous dose of Japanese Encephalitis</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had a severe allergic reaction after a previous dose of Japanese Encephalitis vaccine.</contraindicationText>
<beginAge/>
<endAge/>
</contraindication>
<contraindication>
<observationCode>115</observationCode>
<observationTitle>Severe allergic reaction to protamine sulfate</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had a severe allergic reaction to protamine sulfate.</contraindicationText>
<beginAge/>
<endAge/>
</contraindication>
</vaccineGroup>
</contraindications>
<series>
<seriesName>Japanese Encephalitis risk 2-dose series</seriesName>
<targetDisease>Japanese Encephalitis</targetDisease>
<vaccineGroup>Japanese Encephalitis</vaccineGroup>
<seriesAdminGuidance>ACIP recommends that if the primary series of JE-VC was administered greater than 1 year previously, a booster dose may be given before potential JE virus exposure. ACIP recommendations should be consulted for information on prevention of JE and settings in which JE vaccine is recommended, can be considered, or is not recommended. Data on the response to a booster dose administered greater than 2 years after the primary series of JE-VC are not available. Data on the need for and timing of additional booster doses also are not available.</seriesAdminGuidance>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>Yes</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>1</seriesPreference>
<minAgeToStart/>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Travelers who plan to spend a month or longer in endemic areas during the JE virus transmission season</text>
<code>165</code>
</observationCode>
<description>Administer to persons who plan to spend a month or longer in endemic areas during the JE virus transmission season.</description>
<beginAge>2 months</beginAge>
<endAge/>
<guidance>This includes long-term travelers (greater than or equal to 1 month), recurrent travelers, or expatriates who will be based in urban areas but are likely to visit endemic rural or agricultural areas during a high-risk period of JE virus transmission.JE vaccine should be considered for short-term (less than 1 month) travelers whose itinerary or activities might increase their risk for exposure to JE virus. JE vaccine is not recommended for short-term travelers whose visit will be restricted to urban areas.
The series should be completed greater than or equal to 1 week before travel.</guidance>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>2 months - 4 days</absMinAge>
<minAge>2 months</minAge>
<earliestRecAge>2 months</earliestRecAge>
<latestRecAge/>
<maxAge/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Japanese Encephalitis, VC</vaccineType>
<cvx>134</cvx>
<beginAge>2 months</beginAge>
<endAge>3 years</endAge>
<tradeName/>
<mvx/>
<volume>0.25</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Japanese Encephalitis, VC</vaccineType>
<cvx>134</cvx>
<beginAge>3 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Japanese Encephalitis, VC</vaccineType>
<cvx>134</cvx>
<beginAge>2 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Japanese Encephalitis, VC</vaccineType>
<cvx>134</cvx>
<beginAge>2 months</beginAge>
<endAge>3 years</endAge>
<tradeName/>
<mvx/>
<volume>0.25</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Japanese Encephalitis, VC</vaccineType>
<cvx>134</cvx>
<beginAge>3 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Japanese Encephalitis, VC</vaccineType>
<cvx>134</cvx>
<beginAge>2 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
</antigenSupportingData>
